Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 237 entries
Sorted by: Best Match Show Resources per page
Resolving immune cells with patrolling behaviour by magnetic resonance time-lapse single cell tracking.

EBioMedicine

Masthoff M, Freppon FN, Zondler L, Wilken E, Wachsmuth L, Niemann S, Schwarz C, Fredrich I, Havlas A, Block H, Gerwing M, Helfen A, Heindel W, Zarbock A, Wildgruber M, Faber C.
PMID: 34742131
EBioMedicine. 2021 Nov;73:103670. doi: 10.1016/j.ebiom.2021.103670. Epub 2021 Nov 04.

BACKGROUND: Immune cells show distinct motion patterns that change upon inflammatory stimuli. Monocytes patrol the vasculature to screen for pathogens, thereby exerting an early task of innate immunity. Here, we aimed to non-invasively analyse single patrolling monocyte behaviour upon...

Cite
Masthoff M, Freppon FN, Zondler L, et al. Resolving immune cells with patrolling behaviour by magnetic resonance time-lapse single cell tracking. EBioMedicine. 2021;73:103670doi: 10.1016/j.ebiom.2021.103670.
Masthoff, M., Freppon, F. N., Zondler, L., Wilken, E., Wachsmuth, L., Niemann, S., Schwarz, C., Fredrich, I., Havlas, A., Block, H., Gerwing, M., Helfen, A., Heindel, W., Zarbock, A., Wildgruber, M., & Faber, C. (2021). Resolving immune cells with patrolling behaviour by magnetic resonance time-lapse single cell tracking. EBioMedicine, 73103670. https://doi.org/10.1016/j.ebiom.2021.103670
Masthoff, Max, et al. "Resolving immune cells with patrolling behaviour by magnetic resonance time-lapse single cell tracking." EBioMedicine vol. 73 (2021): 103670. doi: https://doi.org/10.1016/j.ebiom.2021.103670
Masthoff M, Freppon FN, Zondler L, Wilken E, Wachsmuth L, Niemann S, Schwarz C, Fredrich I, Havlas A, Block H, Gerwing M, Helfen A, Heindel W, Zarbock A, Wildgruber M, Faber C. Resolving immune cells with patrolling behaviour by magnetic resonance time-lapse single cell tracking. EBioMedicine. 2021 Nov;73:103670. doi: 10.1016/j.ebiom.2021.103670. Epub 2021 Nov 04. PMID: 34742131; PMCID: PMC8581510.
Copy Download .nbib Format: NLM
Fighting sexual violence in Egypt on social media: A visual essay on assault police.

Global public health

Marzouk A, Vanderveen G.
PMID: 34686112
Glob Public Health. 2021 Oct 22;1-13. doi: 10.1080/17441692.2021.1991972. Epub 2021 Oct 22.

In this essay, we explore how Instagram-based account 'Assault Police' uses the tools of social media to name and shame (alleged) perpetrators and to give testimonies of sexually intimidating, violent experiences. We propose the concept of 'framing' to study...

Cite
Marzouk A, Vanderveen G. Fighting sexual violence in Egypt on social media: A visual essay on assault police. Glob Public Health. 2021;1-13doi: 10.1080/17441692.2021.1991972.
Marzouk, A., & Vanderveen, G. (2021). Fighting sexual violence in Egypt on social media: A visual essay on assault police. Global public health, 1-13. https://doi.org/10.1080/17441692.2021.1991972
Marzouk, Amr, and Vanderveen, Gabry. "Fighting sexual violence in Egypt on social media: A visual essay on assault police." Global public health vol. (2021): 1-13. doi: https://doi.org/10.1080/17441692.2021.1991972
Marzouk A, Vanderveen G. Fighting sexual violence in Egypt on social media: A visual essay on assault police. Glob Public Health. 2021 Oct 22;1-13. doi: 10.1080/17441692.2021.1991972. Epub 2021 Oct 22. PMID: 34686112.
Copy Download .nbib Format: NLM
Extraction and Characterization of Tunisian .

International journal of analytical chemistry

Zarroug Y, Boulares M, Mejri J, Slimi B, Hamdaoui G, Djebi S, Saidi F, Nasri H, Sfayhi DT, Kharrat M.
PMID: 32831842
Int J Anal Chem. 2020 Aug 04;2020:8868673. doi: 10.1155/2020/8868673. eCollection 2020.

In this study, a new starch has been isolated from acorn (

Cite
Zarroug Y, Boulares M, Mejri J, et al. Extraction and Characterization of Tunisian . Int J Anal Chem. 2020;2020:8868673doi: 10.1155/2020/8868673.
Zarroug, Y., Boulares, M., Mejri, J., Slimi, B., Hamdaoui, G., Djebi, S., Saidi, F., Nasri, H., Sfayhi, D. T., & Kharrat, M. (2020). Extraction and Characterization of Tunisian . International journal of analytical chemistry, 20208868673. https://doi.org/10.1155/2020/8868673
Zarroug, Youkabed, et al. "Extraction and Characterization of Tunisian ." International journal of analytical chemistry vol. 2020 (2020): 8868673. doi: https://doi.org/10.1155/2020/8868673
Zarroug Y, Boulares M, Mejri J, Slimi B, Hamdaoui G, Djebi S, Saidi F, Nasri H, Sfayhi DT, Kharrat M. Extraction and Characterization of Tunisian . Int J Anal Chem. 2020 Aug 04;2020:8868673. doi: 10.1155/2020/8868673. eCollection 2020. PMID: 32831842; PMCID: PMC7424496.
Copy Download .nbib Format: NLM
The AKI care bundle: all bundle components are created equal-are they?.

Intensive care medicine

von Groote TC, Ostermann M, Forni LG, Meersch-Dini M, Zarbock A.
PMID: 34921624
Intensive Care Med. 2021 Dec 18; doi: 10.1007/s00134-021-06601-0. Epub 2021 Dec 18.

No abstract available.

Cite
von Groote TC, Ostermann M, Forni LG, et al. The AKI care bundle: all bundle components are created equal-are they?. Intensive Care Med. 2021;doi: 10.1007/s00134-021-06601-0.
von Groote, T. C., Ostermann, M., Forni, L. G., Meersch-Dini, M., Zarbock, A. (2021). The AKI care bundle: all bundle components are created equal-are they?. Intensive care medicine, . https://doi.org/10.1007/s00134-021-06601-0
von Groote, Thilo C, et al. "The AKI care bundle: all bundle components are created equal-are they?." Intensive care medicine vol. (2021). doi: https://doi.org/10.1007/s00134-021-06601-0
von Groote TC, Ostermann M, Forni LG, Meersch-Dini M, Zarbock A. The AKI care bundle: all bundle components are created equal-are they?. Intensive Care Med. 2021 Dec 18; doi: 10.1007/s00134-021-06601-0. Epub 2021 Dec 18. PMID: 34921624.
Copy Download .nbib Format: NLM
COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult.

Revista espanola de anestesiologia y reanimacion

Elouardi Y, Rebahi H, Zarrouki Y, Ziadi A, Younous S, Samkaoui MA.
PMID: 35031265
Rev Esp Anestesiol Reanim (Engl Ed). 2022 Jan 07; doi: 10.1016/j.redare.2020.11.009. Epub 2022 Jan 07.

Recently, few reports have described a serious condition linked to SARS-CoV-2 that mimics Kawasaki disease called multisystem inflammatory syndrome, especially in children (MIS-C) and young adults. In this work, we report on a severe form of MIS in a...

Cite
Elouardi Y, Rebahi H, Zarrouki Y, et al. COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult. Rev Esp Anestesiol Reanim (Engl Ed). 2022;doi: 10.1016/j.redare.2020.11.009.
Elouardi, Y., Rebahi, H., Zarrouki, Y., Ziadi, A., Younous, S., & Samkaoui, M. A. (2022). COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult. Revista espanola de anestesiologia y reanimacion, . https://doi.org/10.1016/j.redare.2020.11.009
Elouardi, Y, et al. "COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult." Revista espanola de anestesiologia y reanimacion vol. (2022). doi: https://doi.org/10.1016/j.redare.2020.11.009
Elouardi Y, Rebahi H, Zarrouki Y, Ziadi A, Younous S, Samkaoui MA. COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult. Rev Esp Anestesiol Reanim (Engl Ed). 2022 Jan 07; doi: 10.1016/j.redare.2020.11.009. Epub 2022 Jan 07. PMID: 35031265; PMCID: PMC8739010.
Copy Download .nbib Format: NLM
COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult.

Revista espanola de anestesiologia y reanimacion

Elouardi Y, Rebahi H, Zarrouki Y, Ziadi A, Younous S, Samkaoui MA.
PMID: 35031265
Rev Esp Anestesiol Reanim (Engl Ed). 2022 Jan 07; doi: 10.1016/j.redare.2020.11.009. Epub 2022 Jan 07.

Recently, few reports have described a serious condition linked to SARS-CoV-2 that mimics Kawasaki disease called multisystem inflammatory syndrome, especially in children (MIS-C) and young adults. In this work, we report on a severe form of MIS in a...

Cite
Elouardi Y, Rebahi H, Zarrouki Y, et al. COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult. Rev Esp Anestesiol Reanim (Engl Ed). 2022;doi: 10.1016/j.redare.2020.11.009.
Elouardi, Y., Rebahi, H., Zarrouki, Y., Ziadi, A., Younous, S., & Samkaoui, M. A. (2022). COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult. Revista espanola de anestesiologia y reanimacion, . https://doi.org/10.1016/j.redare.2020.11.009
Elouardi, Y, et al. "COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult." Revista espanola de anestesiologia y reanimacion vol. (2022). doi: https://doi.org/10.1016/j.redare.2020.11.009
Elouardi Y, Rebahi H, Zarrouki Y, Ziadi A, Younous S, Samkaoui MA. COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult. Rev Esp Anestesiol Reanim (Engl Ed). 2022 Jan 07; doi: 10.1016/j.redare.2020.11.009. Epub 2022 Jan 07. PMID: 35031265.
Copy Download .nbib Format: NLM
Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy.

Molecular therapy. Nucleic acids

Aupy P, Echevarría L, Relizani K, Zarrouki F, Haeberli A, Komisarski M, Tensorer T, Jouvion G, Svinartchouk F, Garcia L, Goyenvalle A.
PMID: 31881528
Mol Ther Nucleic Acids. 2020 Mar 06;19:371-383. doi: 10.1016/j.omtn.2019.11.020. Epub 2019 Nov 27.

Tricyclo-DNA (tcDNA) antisense oligonucleotides (ASOs) hold promise for therapeutic splice-switching applications and the treatment of Duchenne muscular dystrophy (DMD) in particular. We have previously reported the therapeutic potential of tcDNA-ASO in mouse models of DMD, highlighting their unique pharmaceutical...

Cite
Aupy P, Echevarría L, Relizani K, et al. Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy. Mol Ther Nucleic Acids. 2019;19:371-383doi: 10.1016/j.omtn.2019.11.020.
Aupy, P., Echevarría, L., Relizani, K., Zarrouki, F., Haeberli, A., Komisarski, M., Tensorer, T., Jouvion, G., Svinartchouk, F., Garcia, L., & Goyenvalle, A. (2020). Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy. Molecular therapy. Nucleic acids, 19371-383. https://doi.org/10.1016/j.omtn.2019.11.020
Aupy, Philippine, et al. "Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy." Molecular therapy. Nucleic acids vol. 19 (2020): 371-383. doi: https://doi.org/10.1016/j.omtn.2019.11.020
Aupy P, Echevarría L, Relizani K, Zarrouki F, Haeberli A, Komisarski M, Tensorer T, Jouvion G, Svinartchouk F, Garcia L, Goyenvalle A. Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy. Mol Ther Nucleic Acids. 2020 Mar 06;19:371-383. doi: 10.1016/j.omtn.2019.11.020. Epub 2019 Nov 27. PMID: 31881528; PMCID: PMC7063478.
Copy Download .nbib Format: NLM
Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer.

Medical sciences (Basel, Switzerland)

Rawla P, Barsouk A, Hadjinicolaou AV, Barsouk A.
PMID: 31366129
Med Sci (Basel). 2019 Jul 30;7(8). doi: 10.3390/medsci7080083.

Colorectal cancer (CRC) is the third leading cause of cancer deaths, and while mortality has largely improved in the developed world, five-year survival for metastatic disease remains dismally low at only 15%. Fortunately, nearly a dozen targeted therapies and...

Cite
Rawla P, Barsouk A, Hadjinicolaou AV, et al. Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer. Med Sci (Basel). 2019;7(8)doi: 10.3390/medsci7080083.
Rawla, P., Barsouk, A., Hadjinicolaou, A. V., & Barsouk, A. (2019). Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer. Medical sciences (Basel, Switzerland), 7(8), . https://doi.org/10.3390/medsci7080083
Rawla, Prashanth, et al. "Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer." Medical sciences (Basel, Switzerland) vol. 7,8 (2019). doi: https://doi.org/10.3390/medsci7080083
Rawla P, Barsouk A, Hadjinicolaou AV, Barsouk A. Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer. Med Sci (Basel). 2019 Jul 30;7(8). doi: 10.3390/medsci7080083. PMID: 31366129; PMCID: PMC6723550.
Copy Download .nbib Format: NLM
Report of the first AKI Round Table meeting: an initiative of the ESICM AKI Section.

Intensive care medicine experimental

Ostermann M, Schneider A, Rimmele T, Bobek I, van Dam M, Darmon M, Forni L, Joannes-Boyau O, Joannidis M, Legrand M, Prowle J, Zarbock A, Hoste E.
PMID: 31811522
Intensive Care Med Exp. 2019 Dec 07;7(1):69. doi: 10.1186/s40635-019-0280-z.

PURPOSE: Critical Care Nephrology is an emerging sub-specialty of Critical Care. Despite increasing awareness about the serious impact of acute kidney injury (AKI) and renal replacement therapy (RRT), important knowledge gaps persist. This report represents a summary of a...

Cite
Ostermann M, Schneider A, Rimmele T, et al. Report of the first AKI Round Table meeting: an initiative of the ESICM AKI Section. Intensive Care Med Exp. 2019;7(1):69doi: 10.1186/s40635-019-0280-z.
Ostermann, M., Schneider, A., Rimmele, T., Bobek, I., van Dam, M., Darmon, M., Forni, L., Joannes-Boyau, O., Joannidis, M., Legrand, M., Prowle, J., Zarbock, A., & Hoste, E. (2019). Report of the first AKI Round Table meeting: an initiative of the ESICM AKI Section. Intensive care medicine experimental, 7(1), 69. https://doi.org/10.1186/s40635-019-0280-z
Ostermann, M, et al. "Report of the first AKI Round Table meeting: an initiative of the ESICM AKI Section." Intensive care medicine experimental vol. 7,1 (2019): 69. doi: https://doi.org/10.1186/s40635-019-0280-z
Ostermann M, Schneider A, Rimmele T, Bobek I, van Dam M, Darmon M, Forni L, Joannes-Boyau O, Joannidis M, Legrand M, Prowle J, Zarbock A, Hoste E. Report of the first AKI Round Table meeting: an initiative of the ESICM AKI Section. Intensive Care Med Exp. 2019 Dec 07;7(1):69. doi: 10.1186/s40635-019-0280-z. PMID: 31811522; PMCID: PMC6898702.
Copy Download .nbib Format: NLM
The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy- a nationwide propensity score adjusted analysis.

Journal of diabetes and its complications

Lilja E, Gottsäter A, Miftaraj M, Ekelund J, Eliasson B, Svensson AM, Zarrouk M, Nilsson P, Acosta S.
PMID: 32828647
J Diabetes Complications. 2021 Feb;35(2):107675. doi: 10.1016/j.jdiacomp.2020.107675. Epub 2020 Jul 16.

AIM: To investigate the risk of major amputation after elective endovascular therapy in patients with chronic limb threatening ischemia (CLTI) comparing patients with and without diabetes mellitus (DM).METHODS: In this nationwide cohort study, all patients registered in the Swedish...

Cite
Lilja E, Gottsäter A, Miftaraj M, et al. The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy- a nationwide propensity score adjusted analysis. J Diabetes Complications. 2020;35(2):107675doi: 10.1016/j.jdiacomp.2020.107675.
Lilja, E., Gottsäter, A., Miftaraj, M., Ekelund, J., Eliasson, B., Svensson, A. M., Zarrouk, M., Nilsson, P., & Acosta, S. (2021). The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy- a nationwide propensity score adjusted analysis. Journal of diabetes and its complications, 35(2), 107675. https://doi.org/10.1016/j.jdiacomp.2020.107675
Lilja, Erika, et al. "The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy- a nationwide propensity score adjusted analysis." Journal of diabetes and its complications vol. 35,2 (2021): 107675. doi: https://doi.org/10.1016/j.jdiacomp.2020.107675
Lilja E, Gottsäter A, Miftaraj M, Ekelund J, Eliasson B, Svensson AM, Zarrouk M, Nilsson P, Acosta S. The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy- a nationwide propensity score adjusted analysis. J Diabetes Complications. 2021 Feb;35(2):107675. doi: 10.1016/j.jdiacomp.2020.107675. Epub 2020 Jul 16. PMID: 32828647.
Copy Download .nbib Format: NLM
Identification and Characterization of a Novel Recurrent .

Genes

Zayoud K, Kraoua I, Chikhaoui A, Calmels N, Bouchoucha S, Obringer C, Crochemore C, Najjar D, Zarrouk S, Miladi N, Laugel V, Ricchetti M, Turki I, Yacoub-Youssef H.
PMID: 34946871
Genes (Basel). 2021 Nov 29;12(12). doi: 10.3390/genes12121922.

Cockayne syndrome (CS) is a rare disease caused by mutations in

Cite
Zayoud K, Kraoua I, Chikhaoui A, et al. Identification and Characterization of a Novel Recurrent . Genes (Basel). 2021;12(12)doi: 10.3390/genes12121922.
Zayoud, K., Kraoua, I., Chikhaoui, A., Calmels, N., Bouchoucha, S., Obringer, C., Crochemore, C., Najjar, D., Zarrouk, S., Miladi, N., Laugel, V., Ricchetti, M., Turki, I., & Yacoub-Youssef, H. (2021). Identification and Characterization of a Novel Recurrent . Genes, 12(12), . https://doi.org/10.3390/genes12121922
Zayoud, Khouloud, et al. "Identification and Characterization of a Novel Recurrent ." Genes vol. 12,12 (2021). doi: https://doi.org/10.3390/genes12121922
Zayoud K, Kraoua I, Chikhaoui A, Calmels N, Bouchoucha S, Obringer C, Crochemore C, Najjar D, Zarrouk S, Miladi N, Laugel V, Ricchetti M, Turki I, Yacoub-Youssef H. Identification and Characterization of a Novel Recurrent . Genes (Basel). 2021 Nov 29;12(12). doi: 10.3390/genes12121922. PMID: 34946871.
Copy Download .nbib Format: NLM
Chemical Risk Factors of Primary Liver Cancer: An Update.

Hepatic medicine : evidence and research

Barsouk A, Thandra KC, Saginala K, Rawla P, Barsouk A.
PMID: 33447099
Hepat Med. 2021 Jan 05;12:179-188. doi: 10.2147/HMER.S278070. eCollection 2020.

Primary liver cancer has the sixth highest incidence and fourth highest cancer mortality worldwide. Hepatitis B is the leading cause of liver cancer, though its incidence is decreasing with vaccination. Alcohol is the leading cause of liver transplant, cirrhosis,...

Cite
Barsouk A, Thandra KC, Saginala K, et al. Chemical Risk Factors of Primary Liver Cancer: An Update. Hepat Med. 2021;12:179-188doi: 10.2147/HMER.S278070.
Barsouk, A., Thandra, K. C., Saginala, K., Rawla, P., & Barsouk, A. (2020). Chemical Risk Factors of Primary Liver Cancer: An Update. Hepatic medicine : evidence and research, 12179-188. https://doi.org/10.2147/HMER.S278070
Barsouk, Adam, et al. "Chemical Risk Factors of Primary Liver Cancer: An Update." Hepatic medicine : evidence and research vol. 12 (2020): 179-188. doi: https://doi.org/10.2147/HMER.S278070
Barsouk A, Thandra KC, Saginala K, Rawla P, Barsouk A. Chemical Risk Factors of Primary Liver Cancer: An Update. Hepat Med. 2021 Jan 05;12:179-188. doi: 10.2147/HMER.S278070. eCollection 2020. PMID: 33447099; PMCID: PMC7801911.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 237 entries